Loading…
Loading…
pharmaceuticals
Cellares is the first Integrated Development and Manufacturing Organization (IDMO), providing global cell therapy development and manufacturing services through an Industry 4.0 approach to the mass manufacture of living drugs. The company enables drug sponsors to develop, scale, and commercialize cell therapies with the capacity, reliability, and economics required to meet total patient demand. Cellares' fully automated platforms, Cell Shuttle for end-to-end manufacturing and Cell Q for automated quality control, are deployed across its global network of IDMO Smart Factories. These technologies deliver industry-leading manufacturing economics, higher process success rates, and the ability to produce up to 10x more batches than conventional CDMOs with comparable footprint and headcount. The Cell Shuttle is the first cell therapy manufacturing platform to receive the FDA's Advanced Manufacturing Technology (AMT) designation, with a 100% automation success rate across more than a dozen automated processes. Cellares has achieved key clinical validation milestones, including FDA clearance of IND Amendments enabling active clinical manufacturing on the Cell Shuttle and the successful dosing of first patients in partner clinical trials across multiple therapeutic areas, including oncology and autoimmune indications. Headquartered in South San Francisco, California, Cellares operates Smart Factories in Bridgewater, New Jersey, Leiden, the Netherlands, and Kashiwa City, Japan, purpose-built to support clinical and commercial programs and expand access to life-saving cell therapies worldwide.
Cellares is the first Integrated Development and Manufacturing Organization (IDMO), providing global cell therapy development and manufacturing services through an Industry 4.0 approach to the mass manufacture of living drugs. The company enables drug sponsors to develop, scale, and commercialize cell therapies with the capacity, reliability, and economics required to meet total patient demand. Cellares' fully automated platforms, Cell Shuttle for end-to-end manufacturing and Cell Q for automated quality control, are deployed across its global network of IDMO Smart Factories. These technologies deliver industry-leading manufacturing economics, higher process success rates, and the ability to produce up to 10x more batches than conventional CDMOs with comparable footprint and headcount. The Cell Shuttle is the first cell therapy manufacturing platform to receive the FDA's Advanced Manufacturing Technology (AMT) designation, with a 100% automation success rate across more than a dozen automated processes. Cellares has achieved key clinical validation milestones, including FDA clearance of IND Amendments enabling active clinical manufacturing on the Cell Shuttle and the successful dosing of first patients in partner clinical trials across multiple therapeutic areas, including oncology and autoimmune indications. Headquartered in South San Francisco, California, Cellares operates Smart Factories in Bridgewater, New Jersey, Leiden, the Netherlands, and Kashiwa City, Japan, purpose-built to support clinical and commercial programs and expand access to life-saving cell therapies worldwide.
Cellares has been mentioned across 3 podcasts.
Represent this company? Request removal or email privacy@pitchcentric.com.
FAQs
If you have a concern about deliverability, AI quality, data privacy, or whether this will actually work for your specific situation, it's probably answered below.
Founder Solo gives you 50 AI pitches per month using the credit model (Standard pitches cost 1 credit, Enriched pitches cost 2). Founder Pro raises that to 200 credits per month and adds full Booking Probability access, unlimited Magic Match, Apollo enrichment credits, and data export capabilities. Both plans use the same credit system, so you can stretch your monthly budget further by using Standard-mode drafting.
Agency tiers have no base fee. You pay per managed client and per talent profile. Agency Standard is $199 per client per month; Agency Pro is $399 per client per month. Both add $39 per talent profile per month. Your own team's user seats are always free.
A talent profile represents one person (founder, executive, or spokesperson) you are booking onto podcasts. It includes their bio, topics, headshots, and outreach history. Team plans include 5 profiles; agency plans are pay-as-you-go.
Yes, at any time. Upgrades take effect immediately; downgrades apply at the end of the current billing period. Contact support if you need help migrating between plan families.
Every paid plan includes a 15-day free trial. Your card is saved at signup but you will not be charged until day 16. Cancel any time from your dashboard.
You keep access until the end of your current billing period. No charges after that. Your data is retained for 30 days in case you reactivate.
Yes. Select Annual on the pricing toggle and the discounted price is applied automatically at checkout. The annual price shown is the full year cost.
That is our Enterprise tier. Contact our sales team and we will build a custom plan with volume pricing, a dedicated account manager, and SLA guarantees.
